<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00251563</url>
  </required_header>
  <id_info>
    <org_study_id>ICP036</org_study_id>
    <nct_id>NCT00251563</nct_id>
  </id_info>
  <brief_title>Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <brief_summary>
    <textblock>
      Environmental and genetic factors may play a role in the progression of cancer. The goal of&#xD;
      this project is to establish a series of cross-sectional / case-control studies to evaluate&#xD;
      risk factors of cancer in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to investigate the epidemiologic, genetic, laboratory and clinical&#xD;
      characterization of individuals with cancer (gastric, colorectal, esophageal, liver,&#xD;
      prostate, lung, breast and endometrial cancer, etc.). We will accrue approximately 1600&#xD;
      patients as experimental group. The control group consists of subjects who will be confirmed&#xD;
      without cancer. We will explore the environmental (including family history, life style,&#xD;
      diet, physical activity, neuropsychological functioningï¼Œplasma levels of oxidative stress&#xD;
      factors, angiogenic factors, and tumor markers, etc.) and genetic (including oxidative stress&#xD;
      factors and angiogenic factors, etc.) risk factors. We will study the association between&#xD;
      various environmental risk factors with the clinical characterization and correlation between&#xD;
      the genetic polymorphisms and the presence of various cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2005</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <condition>Cancer</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  This is a study only of Chinese. Subjects will be allowed to participate if they&#xD;
             self-identify as Chinese. The age range of the participants will be between 18 and 89&#xD;
             years. Individuals with cancer (gastric, colorectal, esophageal, liver, prostate,&#xD;
             lung, breast and endometrial cancer, etc.) will be allowed to participate. To&#xD;
             participate in the study as the control, subjects should be confirmed without cancer.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bin Wang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bin Wang, Ph.D</last_name>
    <phone>0086-25-86862884</phone>
    <email>binwang@njmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Wang, Ph.D</last_name>
      <phone>0086-25-86862884</phone>
      <email>binwang@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2005</verification_date>
  <study_first_submitted>November 9, 2005</study_first_submitted>
  <study_first_submitted_qc>November 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2005</study_first_posted>
  <last_update_submitted>October 12, 2006</last_update_submitted>
  <last_update_submitted_qc>October 12, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2006</last_update_posted>
  <keyword>Cancer,Risk factors</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

